Fingerprint
Dive into the research topics where Dexing Fang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells
Rafei, H., Basar, R., Acharya, S., Hsu, Y. S., Liu, P., Zhang, D., Bohn, T., Liang, Q., Mohanty, V., Upadhyay, R., Li, P., Phadatare, P., Dede, M., Xiong, D., Fan, H., Jones, C. M., Kunz, S., Daher, M., Nunez Cortes, A. K. & Shanley, M. & 38 others, , Jul 24 2025, In: Nature. 643, 8073, p. 1076-1086 11 p.Research output: Contribution to journal › Article › peer-review
Open Access21 Link opens in a new tab Scopus citations -
BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML
Kumar, B., Singh, A., Basar, R., Uprety, N., Li, Y., Fan, H., Cortes, A. K. N., Kaplan, M., Acharya, S., Shaim, H., Xu, A. C., Wu, M., Ensley, E., Fang, D., Banerjee, P. P., Garcia, L. M., Tiberti, S., Lin, P., Rafei, H. & Munir, M. N. & 30 others, , Sep 11 2024, In: Science translational medicine. 16, 764, eadp0004.Research output: Contribution to journal › Article › peer-review
Open Access21 Link opens in a new tab Scopus citations -
Ex Vivo Expanded Cord Blood Natural Killer Cells Combined with Rituximab and High-Dose Chemotherapy and Autologous Stem Cell Transplantation for B Cell Non-Hodgkin Lymphoma
Nieto, Y., Banerjee, P., Kaur, I., Kim, K. H., Fang, D., Thall, P. F., Griffin, L., Barnett, M., Basar, R., Hosing, C., Ramdial, J., Srour, S., Daher, M., Marin, D., Jiang, X., Chen, K., Champlin, R., Shpall, E. J. & Rezvani, K., Feb 2024, In: Transplantation and Cellular Therapy. 30, 2, p. 203.e1-203.e9Research output: Contribution to journal › Article › peer-review
Open Access7 Link opens in a new tab Scopus citations -
A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with Verteporfin
Liang, J., Fang, D., Gumin, J., Najem, H., Sooreshjani, M., Song, R., Sabbagh, A., Kong, L. Y., Duffy, J., Balyasnikova, I. V., Pollack, S. M., Puduvalli, V. K. & Heimberger, A. B., Feb 2023, In: Cancers. 15, 4, 1085.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Scopus citations -
A first-in-human Phase i trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma
Groot, J. D., Ott, M., Wei, J., Kassab, C., Fang, D., Najem, H., O'Brien, B., Weathers, S. P., Matsouka, C. K., Majd, N. K., Harrison, R. A., Fuller, G. N., Huse, J. T., Long, J. P., Sawaya, R., Rao, G., Macdonald, T. J., Priebe, W., Decuypere, M. & Heimberger, A. B., Jun 2022, In: CNS oncology. 11, 2, CNS87.Research output: Contribution to journal › Article › peer-review
Open Access67 Link opens in a new tab Scopus citations